EMA, MHRA to review Vertex’ Kaftrio for children with CF
If approved, up to 2,000 children with CF would be eligible for treatment with the drug
Read Moreby Selina McKee | May 20, 2021 | News | 0
If approved, up to 2,000 children with CF would be eligible for treatment with the drug
Read Moreby Selina McKee | Aug 24, 2020 | News | 0
Clearance was based on two global Phase III studies showing statistically significant improvements in lung function
Read Moreby Selina McKee | Jul 23, 2020 | News | 0
The letter of intent should secure access to the combination for people with cystic fibrosis upon its regulatory approval
Read Moreby Selina McKee | Jul 1, 2020 | News | 0
CF patients in England will be among the first in Europe to benefit from access to Kaftrio, if the medicine is approved by the EC
Read Moreby Selina McKee | Jun 29, 2020 | News | 0
The recommendations include a conditional approval for Gilead’s Veklury (remdesivir) for COVID-19
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
